Indonesian airline Garuda has failed in its bid to stay a $19 million penalty for its role in a fuel surcharge cartel after telling the Federal Court it has debts of $480 million, with a judge saying he would be allowing the company to trade while insolvent if he granted the stay.
Australian logistics company Linfox has taken its $45 million fuel tax credit challenge to the Full Federal Court, arguing its trucks are being over-taxed on major toll roads across the country.
The Full Federal Court has dismissed two appeals by convicted land mogul Allen Caratti seeking to prevent liquidators of five of his companies from obtaining documents seized in two 2015 raids by the Australian Federal Police.
The High Court has unanimously upheld the validity of the Australian Public Service code of conduct, after a former public servant mounted a freedom of speech challenge after being sacked for anonymously tweeting thousands of critical comments about government immigration policy and members of parliament.
An appeal by gaming giant Aristocrat Technologies of an IP Australia ruling revoking four of its patents will head to trial in September ahead of outcomes in two high stakes cases over the patentability of computer software.
The Australian Broadcasting Corporation, which is fighting the legality of a police raid on its Sydney headquarters, has urged the Federal Court to order the Australian Federal Police to hand over a document it produced as rationale for obtaining a search warrant.
The Australian Competition and Consumer Commission has appealed a Federal Court judgment tossing its consumer case against Kimberly-Clark over “flushable” wipes.
The Australian Securities and Investments Commission is planning to sue ANZ over $35 million in allegedly illegal customer fees, which were also at the centre of two class actions settlements reached last year under which customers are expected to walk away with no more than $100 apiece.
A judge has slapped a $10 million fine on online supplement company Peptide Clinics for advertising prescription-only drugs in breach of the Therapeutic Goods Act.
NSW Ports Operations has denied claims that an agreement for the privatisation of its subsidiaries Port Botany and Port Kembla stymied competition, describing the allegations made by the Australian Competition and Consumer Commission as “slight or hypothetical”.